Home | Welcome to Contract Pharma   
Last Updated Saturday, January 31 2015

Print RSS Feed

Search Results for 'Financial Report: Johnson'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Published January 20, 2015
Pharmaceutical sales up 15% for the year Read More »
Published October 14, 2014
Pharmaceutical sales up 18% in the quarter, new products drive growth Read More »
Published July 15, 2014
Revenues up 9% in the quarter driven by new products Read More »
Published April 16, 2014
Revenues up 3% in the quarter Read More »
Published April 16, 2013
Revenues up 9% in the quarter Read More »
By Michael Martorelli
Published November 6, 2009
Feel Better Now? Ending one year, approaching the next By Michael A. Martorelli It’s always interesting to write a column about an event that is still in my future, but will have already happened by the time you read my words. Th… Read More »
Published July 18, 2006
Johnson & Johnson   2Q Revenues: $13.4 billion (+5%) 2Q Earnings: $2.8 billion (+7%) YTD Revenues: $26.4 billion (+3%) YTD Earnings: $6.1 billion (+13%) Comments: Worldwide pharmaceutical sales were $5.8 billion for the qu… Read More »
Quantifying the Value of Time
By Ben Locwin, Ph.D., Healthcare Science Advisors
Published September 8, 2014
Clinical attrition and quality-adjusted life years make for dissatisfied patients Read More »
By Ed Silverman, Contributing Editor
Published January 24, 2014
When is a patent settlement between drug makers a legitimate deal and not the equivalent of a bribe? This is a question that authorities on both sides of the Atlantic Ocean have been trying to answer for the past few years with varying degrees of suc… Read More »
By Andreas Scherer, Ph.D.
Published March 21, 2012
Holy Grail or Buying Time? Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On